Search research articles
Contact Us
Filters
Showing results (41-50 of 71) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2009
Structure-activity relationship studies of small-molecule inhibitors of Wnt response
Jianming Lu, Zhiqiang Ma, Jen-Chieh Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2011
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
Xiaoli Zhang, Amy S Farrell, Colin J Daniel, et al.
Molecular Cell
|
November 26, 2003
Hedgehog signal transduction via Smoothened association with a cytoplasmic complex scaffolded by the atypical kinesin, Costal-2
Lawrence Lum, Chi Zhang, Sekyung Oh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 29, 2012
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial
Muneer H Abidi, Rishi Agarwal, Lois Ayash, et al.
Journal of Molecular and Cellular Cardiology
|
May 17, 2011
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells
Yongming Ren, Min Young Lee, Simon Schliffke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 20, 2012
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation
Zaid Al-Kadhimi, Zartash Gul, Roberto Rodriguez, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 5, 2012
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma
Muneer H Abidi, Zartash Gul, Judith Abrams, et al.
Molecular and Cellular Biology
|
August 5, 2003
Potential role for ADAM15 in pathological neovascularization in mice
Keisuke Horiuchi, Gisela Weskamp, Lawrence Lum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2012
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function
Muneer H Abidi, Rishi Agarwal, Nishant Tageja, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 71) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2009
Structure-activity relationship studies of small-molecule inhibitors of Wnt response
Jianming Lu, Zhiqiang Ma, Jen-Chieh Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2011
Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
Xiaoli Zhang, Amy S Farrell, Colin J Daniel, et al.
Molecular Cell
|
November 26, 2003
Hedgehog signal transduction via Smoothened association with a cytoplasmic complex scaffolded by the atypical kinesin, Costal-2
Lawrence Lum, Chi Zhang, Sekyung Oh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 18, 2013
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma
Divaya Bhutani, Jeffrey Zonder, Jason Valent, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 29, 2012
Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial
Muneer H Abidi, Rishi Agarwal, Lois Ayash, et al.
Journal of Molecular and Cellular Cardiology
|
May 17, 2011
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells
Yongming Ren, Min Young Lee, Simon Schliffke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 20, 2012
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation
Zaid Al-Kadhimi, Zartash Gul, Roberto Rodriguez, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 5, 2012
Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma
Muneer H Abidi, Zartash Gul, Judith Abrams, et al.
Molecular and Cellular Biology
|
August 5, 2003
Potential role for ADAM15 in pathological neovascularization in mice
Keisuke Horiuchi, Gisela Weskamp, Lawrence Lum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2012
A phase I dose-escalation trial of high-dose melphalan with palifermin for cytoprotection followed by autologous stem cell transplantation for patients with multiple myeloma with normal renal function
Muneer H Abidi, Rishi Agarwal, Nishant Tageja, et al.
Page
of 8